Follow us on:

Goodbody Health signing up pharmacies as fast as they can (VIDEO)

Giles
May 6, 2022
8:18 am

Goodbody Health Inc. (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF) CEO Marc Howells joins DirectorsTalk Interviews to update us on company progress after filing its financial statements for the year ending 2021.

Marc shares his views on a under resourced and over burdened NHS, a change in how people manage their health, how Goodbody Health is meeting the massive growing demand for its services and can the company continue to grow at such speed.

Goodbody Health is the parent company for its main brand name “Goodbody” and its trading subsidiaries “Goodbody Wellness Limited” and “Goodbody Botanicals Ltd”

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Research links high cholesterol and dementia as blood tests hold the key to a healthy life March 25, 2022
Urgent need for blood tests as UK cancer diagnoses fall by 50,000 March 18, 2022
NHS loses patients’ confidence as demand for routine blood testing rises March 16, 2022
Goodbody Health confirms strong 2021 revenue continuing into 2022 March 10, 2022
Goodbody Health rolls out blood testing technology March 8, 2022
Goodbody Health announces Normal Course Issuer Bid and Restricted Share Unit Plan March 4, 2022
Goodbody Health move up tier to OTCQB market February 22, 2022
Goodbody Health early detection substantially improves patient outcomes (Interview) February 21, 2022
Goodbody Health opens first clinic in Canada February 18, 2022
Goodbody Health rolling out blood testing through its existing network of clinics February 16, 2022

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.